Back to MW MARSHALL WACE, LLP
RETAShowing 0 of 8 quarters
Position history for MWMARSHALL WACE, LLP's holdings in REATA PHARMACEUTICALS INC-A
As of its Q2 2023 13F, Marshall Wace held 84,508 shares of RETA (Reata Pharmaceuticals), worth $8.6M. Marshall Wace's 13F filings listed RETA from Q3 2022 to Q2 2023, 4 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of RETA: WELLINGTON MANAGEMENT GROUP LLP